|
51
|
199
|
4r670 |
Human constitutive 20s proteasome in complex with carfilzomib |
|
67
|
250
|
4qvwA |
Ycp beta5-a49s-mutant in complex with bortezomib |
|
69
|
225
|
4qz5M |
Ycp beta5-a49t-mutant in complex with onx 0914 |
|
66
|
231
|
4qwiE |
Ycp beta5-a49s-mutant in complex with carfilzomib |
|
68
|
242
|
4qw3D |
Ycp beta5-c63f mutant in complex with bortezomib |
|
61
|
196
|
4qv7N |
Ycp beta5-a50v mutant |
|
60
|
196
|
4qwkN |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
66
|
242
|
4qwfD |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
60
|
222
|
4qlsL |
Ycp in complex with tripeptidic epoxyketone inhibitor 11 |
|
59
|
226
|
4qw0H |
Ycp beta5-a49t-a50v-double mutant in complex with bortezomib |
|
71
|
240
|
4r17C |
Ligand-induced aziridine-formation at subunit beta5 of the yeast 20s proteasome |
|
56
|
222
|
4qz1H |
Ycp beta5-m45t mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
231
|
4qw3E |
Ycp beta5-c63f mutant in complex with bortezomib |
|
57
|
204
|
4qv4I |
Ycp beta5-m45t mutant |
|
61
|
222
|
4qwuL |
Ycp beta5-c52f mutant in complex with bortezomib |
|
55
|
204
|
4qvmI |
Ycp beta5-m45a mutant in complex with bortezomib |
|
67
|
250
|
4qv4A |
Ycp beta5-m45t mutant |
|
69
|
240
|
4qzwC |
Ycp beta5-c52f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
226
|
4qvyH |
Ycp beta5-a49t-mutant in complex with bortezomib |
|
63
|
195
|
4qvmJ |
Ycp beta5-m45a mutant in complex with bortezomib |
|
70
|
243
|
4qzxF |
Ycp beta5-c63f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
250
|
4qw6A |
Ycp beta5-m45v mutant in complex with carfilzomib |
|
59
|
222
|
4qvlL |
Ycp in complex with bortezomib |
|
60
|
195
|
4qv0J |
Ycp beta5-a49t-a50v-double mutant |
|
59
|
196
|
4qvlN |
Ycp in complex with bortezomib |
|
69
|
243
|
4qvpF |
Ycp beta5-m45t mutant in complex with bortezomib |
|
72
|
233
|
4r17M |
Ligand-induced aziridine-formation at subunit beta5 of the yeast 20s proteasome |
|
57
|
222
|
4qz2H |
Ycp beta5-m45i mutant in complex with the epoxyketone inhibitor onx 0914 |
|
66
|
242
|
4qwkD |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
67
|
250
|
4qvvA |
Ycp beta5-a49v mutant in complex with bortezomib |
|
61
|
196
|
4qwlN |
Ycp beta5-a50v mutant in complex with carfilzomib |
|
69
|
233
|
4qw1M |
Ycp beta5-a50v mutant in complex with bortezomib |
|
69
|
212
|
4qv4K |
Ycp beta5-m45t mutant |
|
70
|
240
|
4qz7C |
Ycp beta5-a50v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
65
|
233
|
4qwfM |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
57
|
204
|
4qw4I |
Ycp in complex with carfilzomib |
|
59
|
226
|
4qv6H |
Ycp beta5-a49v mutant |
|
68
|
244
|
4qlqB |
Ycp in complex with tripeptidic epoxyketone inhibitor 8 |
|
66
|
233
|
4qwuM |
Ycp beta5-c52f mutant in complex with bortezomib |
|
66
|
233
|
4qwgM |
Ycp beta5-a49v mutant in complex with carfilzomib |
|
70
|
244
|
4qvnB |
Ycp beta5-m45v mutant in complex with bortezomib |
|
64
|
231
|
4qz6E |
Ycp beta5-a49t-a50v double mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
222
|
4qw6L |
Ycp beta5-m45v mutant in complex with carfilzomib |
|
63
|
241
|
4qvyG |
Ycp beta5-a49t-mutant in complex with bortezomib |
|
60
|
222
|
4quxL |
Ycp beta5-a49t-mutant |
|
59
|
222
|
4qbyL |
Ycp in complex with boc-ala-ala-ala-cho |
|
65
|
231
|
4qzxM |
Ycp beta5-c63f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
243
|
4qw6F |
Ycp beta5-m45v mutant in complex with carfilzomib |
|
69
|
233
|
4qlqM |
Ycp in complex with tripeptidic epoxyketone inhibitor 8 |
|
71
|
244
|
4r00B |
Ycp beta5-c52f mutant in complex with omuralide |
